Literature DB >> 8222177

Transposition of chordae in mitral valve repair. Mid-term results.

M Sousa Uva1, P Grare, V Jebara, J F Fuzelier, M Portoghese, C Acar, J Relland, S Mihaileanu, J N Fabiani, A Carpentier.   

Abstract

BACKGROUND: Prolapse of the anterior mitral leaflet, unlike a posterior prolapse, is a difficult lesion to repair. Leaflet plication and triangular resection are satisfactory techniques only in case of a limited prolapse. Chordal replacement has also been proposed but uses foreign material. The purpose of this report is to assess the results of transposition of chordae for the correction of mitral regurgitation (MR) caused by anterior leaflet prolapse. METHODS AND
RESULTS: Between January 1986 and December 1990, 44 adult patients with MR caused by anterior leaflet prolapse underwent repair with transposition of chordae as one of the techniques. This population was retrospectively studied to assess the early and late results of this procedure. Chordae were transferred from the posterior to the anterior leaflet (n = 25) or from an intermediary to a free edge position on the anterior leaflet (n = 21) (two patients underwent both procedures). Two patients died (4.5%). None required early reoperation. Follow-up was complete and ranged from 18 to 82 months (mean, 40.2 +/- 19 months). No patient died during follow-up. Two patients were reoperated on 6 and 8 months after surgery for recurrent MR unrelated to chordal transfer disruption. Doppler echocardiographic studies were available in 95% of the cases at latest follow-up and showed no or minimal MR (0 to 1/4) in 87.5% of the patients and mild MR (2/4) in 12.5%.
CONCLUSIONS: Transposition of chordae appeared to be a simple and safe procedure for correction of anterior mitral prolapse. Transposition of chordae allowed extension of the indications of valve repair. A longer follow-up will be necessary to draw firm conclusions, but mid-term results are encouraging.

Entities:  

Mesh:

Year:  1993        PMID: 8222177

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Transapical beating-heart chordae implantation in mitral regurgitation: a new horizon for repairing mitral valve prolapse.

Authors:  Patrizio Lancellotti; Marc Radermecker; Rodolphe Durieux; Thomas Modine; Cécile Oury; Khalil Fattouch
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Comparison of artificial neochordae and native chordal transfer in the repair of a flail posterior mitral leaflet: an experimental study.

Authors:  Muralidhar Padala; Benedicte Cardinau; Lazarina I Gyoneva; Vinod H Thourani; Ajit P Yoganathan
Journal:  Ann Thorac Surg       Date:  2013-01-03       Impact factor: 4.330

3.  Mitral Valve Chordae Tendineae: Topological and Geometrical Characterization.

Authors:  Amir H Khalighi; Andrew Drach; Charles H Bloodworth; Eric L Pierce; Ajit P Yoganathan; Robert C Gorman; Joseph H Gorman; Michael S Sacks
Journal:  Ann Biomed Eng       Date:  2016-12-19       Impact factor: 3.934

4.  [Mitral valve regurgitation with anterior mitral leaflet chordal rupture or elongation--repair using the flip-over technique].

Authors:  K Kamohara; R Sakata; Y Nakayama; M Ura; K Mabuni; Y Arai; A Sugimoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-08

5.  Mechanics of Porcine Heart Valves' Strut Chordae Tendineae Investigated as a Leaflet-Chordae-Papillary Muscle Entity.

Authors:  Colton J Ross; Devin W Laurence; Ming-Chen Hsu; Ryan Baumwart; Yan D Zhao; Arshid Mir; Harold M Burkhart; Gerhard A Holzapfel; Yi Wu; Chung-Hao Lee
Journal:  Ann Biomed Eng       Date:  2020-01-31       Impact factor: 3.934

6.  Mitral valve repair: the chordae tendineae.

Authors:  Carlos-A Mestres; José M Bernal
Journal:  J Tehran Heart Cent       Date:  2012-08-31

Review 7.  Mechanics and Microstructure of the Atrioventricular Heart Valve Chordae Tendineae: A Review.

Authors:  Colton J Ross; Junnan Zheng; Liang Ma; Yi Wu; Chung-Hao Lee
Journal:  Bioengineering (Basel)       Date:  2020-03-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.